Daktronics to wind down Irish factory, books up to $13.5 million in charges and corrects capex error
A Form 8-K filed by Daktronics, Inc. on 14 October 2026 discloses board approval for a phased exit of its Ennistymon, Ireland manufacturing facility and separately corrects a capital expenditure figure in its prior quarterly report.
Written and published automatically by the Loro Intelligence Engine from public records. No editor reviewed this before publication.
A Form 8-K filed by Daktronics, Inc. on 14 October 2026 shows its board approved on 12 October 2026 a phased exit of its Ennistymon, Ireland manufacturing facility expected to cost approximately $13.5 million in cumulative charges, and separately corrects a clerical error in its 2 September 2026 Form 10-Q that understated fiscal 2027 capital expenditure projections as $13.2 million instead of the
- Board approval date
- 12 October 2026
- Estimated cumulative charges for Irish phase-out
- approximately $13.5 million
- Severance and termination benefits portion
- $11.7 million
- Asset impairments (PP&E)
- $1.0 million
- Corrected fiscal 2027 capex projection
- approximately $23.4 million (from $13.2 million stated in the 10-Q filed 2 September 2026)
Daktronics, Inc. disclosed in the Form 8-K filed on 14 October 2026 that its board of directors approved manufacturing network optimisation initiatives on 12 October 2026. As part of the initiatives, the company said it will exit the highly customised portions of its international transportation business, which serves rail, bus and roadway customers outside North America, and will begin a phased exit of operations at its Ennistymon, Ireland manufacturing facility. The filing states that Daktronics Ireland Co. Limited, a wholly owned subsidiary, will enter into a plan of termination with the majority of its Irish employees, a process the company says is expected to be substantially complete in the first half of fiscal 2028.
The filing estimates the Irish phase-out will result in cumulative cash and non-cash charges of approximately $13.5 million. Of this, $11.7 million relates to severance, stay bonuses and other termination benefits, $0.8 million relates to the phased exit of operations, legal costs and equipment transfer costs, and $1.0 million relates to asset impairments associated with property, plant and equipment at the Irish facility. The company said approximately $12.3 million of these costs are expected to be recorded during fiscal 2027, with the remainder in the first half of fiscal 2028, and that future cash payments related to the charges are anticipated to be $12.5 million.
In a separate disclosure under Item 8.01, the company said it had identified a clerical error in its Form 10-Q for the quarterly period ended 1 August 2026, which it filed on 2 September 2026. The filing states that page 29 of that report projected total capital expenditures of approximately $13.2 million for fiscal 2027, whereas the company's intended projection at the time of filing was approximately $23.4 million. Daktronics said the correction does not affect its previously reported consolidated financial statements and that it had not identified any other inaccuracies arising from the matter.
The filing does not state the total number of Irish employees affected by the plan of termination or the financial effect, if any, on the company's broader international transportation business beyond the costs outlined.
Primary sources
1 recordEvery factual claim above is drawn from these records. Each link resolves to the publisher’s own copy.